Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes

Cell Biology International

Volumn 36, Issue 11, 2012, Pages 1013-1020

  Bose, Bipasha ^a   Shenoy, Sudheer P ^a   Konda, Sudhakar ^a   Wangikar, Pralhad ^a  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Islets; Agonists and antagonists of insulin pathway; C peptide ELISA; hESC; Pancreatic differentiation

Indexed keywords

ACTIVIN A; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; EMBRYONIC STEM CELL; ENDODERM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN SYNTHESIS; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTIVINS; ANIMALS; BIOLOGICAL MARKERS; C-PEPTIDE; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC STEM CELLS; ENDODERM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDES; STREPTOZOCIN; TRANS-ACTIVATORS; TRETINOIN; VENOMS;

EID: 84867700531     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20120210     Document Type: Article

References (32)

1. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotechnol 2005, 23, 857-61.
2. Bregenholt S, Møldrup A, Blume N, Karlsen AE, Nissen Friedrichsen B, Tornhave D et al. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem Biophys Res Commun 2005, 330, 577-84.
3. D'Alessio DA, Vahl TP. Glucagon-like peptide 1, evolution of an incretin into a treatment for diabetes. Am J Physiol Endocrinol Metab 2004, 286, E882-90.
4. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23, 1534-41.
5. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006, 24, 1392-401.
6. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H et al. Glucagon-like peptide-1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003, 144, 5149-58.
7. Grossman EJ, Lee DD, Tao J, Wilson RA, Park SY, Bell GI et al. Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One 2010, 5, e8749.
8. Guz Y, Montminy MR, Stein R, Leonard J, Gamer LW, Wright CV et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 1995, 121, 11-8.
9. Hang Y, Stein R. MafA and MafB activity in pancreaticβcells. Trends Endocrinol Metab 2011, 22, 364-73.
10. Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn 2004, 229, 176-200.
11. Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007a, 25, 1940-53.
12. Jiang W, Shi Y, Zhao D, Chen S, Yong J, Zhang J. et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res 2007b, 17, 333-44.
13. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371, 606-9.
14. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo, Nat Biotechnol 2008, 26, 443-52.
15. Lumelsky L, Blondel O, Laeng P, Velasco I, Ravin R, McKay R et al. Differentiation of embryonic stem cells into insulin secreting structures similar to pancreatic islets, Science 2009, 292, 1389-94.
16. Madsen OD, Serup P. Towards cell therapy for diabetes. Nat Biotechnol 2006, 24, 1481-3.
17. Mandal A, Tipnis S, Pal R, Ravindran G, Bose B, Patki A et al. Characterization and in vitro differentiation potential of a new human embryonic stem cell line, ReliCellhES1. Differentiation 2006, 74, 81-90.
18. Mandrop-Poulsen T. Diabetes. Br Med J 1998, 316, 1221-5.
19. Matsuoka TA, Artner I, Henderson E, Means A, Sander M, Stein R et al. The MafA transcription factor appears to be responsible for tissuespecific expression of insulin. Proc Natl Acad Sci USA 2004, 101, 2930-3.
20. Michael RR, Rebecca M, James FM, Naji A. Effect of glucagon-like peptide-1 on b- and a-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab 2009, 94, 181-9.
21. Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X et al. Stage-specific signaling through TGF-b family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138, 861-87.
22. Saito H, Takeuchi M, Chida K, Miyajima A. Generation of glucoseresponsive functional islets with a three-dimensional structure from mouse fetal pancreatic cells and iPS cells in vitro. PLoS One 2011, 6, e28209.
23. Schwitzgebel VM, Scheel DW, Conners JR, Kalamaras J, Lee JE, Anderson DJ et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas, Development 2000, 127, 3533-4.
24. Serup P, Madsen OD, Mandrup-Poulsen T. Islet and stem cell transplantation for treating diabetes. Br Med J 2001, 322, 29-32.
25. Shi Y, Hou L, Tang F, Jiang W, Wang P, Ding M et al. Inducing Embryonic stem cells to differentiate into pancreatic beta cells by a novel three step approach using activin A and all-trans retinoic acid, Stem Cells 2005, 23, 93-110.
26. Slack JM. Developmental biology of the pancreas, Development 1995, 121, 1569-80.
27. Soria B, Skoudy A, Martín F. From stem cells to beta cells, new strategies in cell therapy of diabetes mellitus, Diabetologia 2001, 44, 407-15.
28. Van Hoof D, D'Amour KA, German MS. Derivation of insulin-producing cells from human embryonic stem cells, Stem Cell Res 2009, 3, 73-87.
29. Wang H, Brun T, Kataoka K, Sharma AJ, Wollheim CB. MAFA controls genes implicated in insulin biosynthesis and secretion, Diabetologia 2007, 50, 348-58.
30. Wang X, Ye K, Three dimensional differentiations of embryonic stem cells into islet-like insulin producing clusters. Tissue Eng A 2009, 15, 1941-52.
31. Yin D, Tao J, Lee DD, Shen J, Hara M, Lopez J et al. Recovery of islet beta-cell function in streptozotocin-induced diabetic mice, an indirect role for the spleen. Diabetes 2006, 55, 3255-63.
32. Zhang C, Moriguchi T, Kajihara M, Esaki R, Harada A, Shimohata H et al. MafA is a key regulator of glucose stimulated insulin secretion. Mol Cell Biol 2005, 25, 4969-76.